计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175669-100μg |
100μg |
现货 ![]() |
| |
| Ab175669-1mg |
1mg |
现货 ![]() |
| |
| Ab175669-5mg |
5mg |
现货 ![]() |
| |
| Ab175669-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Teclistamab (anti-CD3&BCMA), T 细胞表面糖蛋白的结合剂 CD3 结合剂 |
|---|---|
| 别名 | 特立妥单抗 | CD3抗体 | CD3药靶抗体 | BCMA抗体 | BCMA药靶抗体 | CD3E抗体 | CD3E药靶抗体 | TNFRSF17抗体 | TNFRSF17药靶抗体 |
| 英文别名 | CD3 epsilon antibody | CD3e antibody | CD3e antigen antibody | CD3e antigen epsilon polypeptide (TiT3 complex) antibody | CD3E antigen epsilon polypeptide antibody | CD3E antigen, epsilon subunit antibody | CD3e molecule epsilon antibody | CD3e molecule, |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
| 生化机理 | CD3: The CD3 complex mediates signal transduction. BCMA: Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK. |
| 宿主种属 | 人(Human) |
| 特异性 | CD3E & TNFRSF17 |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 作用类型 | 结合剂 |
| 作用机制 | T 细胞表面糖蛋白的结合剂 CD3 结合剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG4SP |
| 轻链亚型 | lambdaC2 |
| SDS-PAGE | 143.64 kDa |
| 纯化方法 | Protein A purified |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS编号和信息 | 2119595-80-9 |
| 分子类型 | 抗体 |
Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA (red) with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human CD3 protein (rp175910) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 99.33 ng/mL.
Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human BCMA/TNFRSF17 protein (rp169554) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 6.582 ng/mL.
Teclistamab (anti-CD3&BCMA) (Ab175669) - SEC
The purity of Teclistamab (anti-CD3&BCMA) (Ab175669) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175669 | |
| 分析证书 | Ab175669 | |
| 分析证书 | Ab175669 |
| 1. Pillarisetti K, Powers G, Luistro L, Babich A, Baldwin E, Li Y, Zhang X, Mendonça M, Majewski N, Nanjunda R et al.. (2020) Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.. Blood Adv, 4 (18): (4538-4549). [PMID:32956453] |
| 2. Moreau P, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Nooka AK, Martin T, Rosinol L, Chari A et al.. (2022) Teclistamab in Relapsed or Refractory Multiple Myeloma.. N Engl J Med, 387 (6): (495-505). [PMID:35661166] |
| 3. (2022) Teclistamab Approved for Myeloma.. Cancer Discov, (OF1). [PMID:36321843] |